Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 23, 2026 19:05 ET | Source: Curative Biotechnology, Inc. 

Curative Biotechnology Announces Reverse Stock Split and Strategic Progress Toward OTCQB Uplisting

Strengthening Capital Structure and Advancing Clinical Development Strategy Palm Beach Gardens, FL, March 23, 2026 (GLOBE NEWSWIRE) -- Curative Biotechnology, Inc. (OTC: CUBTD) (“Curative” or the...
March 23, 2026 16:05 ET | Source: Surrozen, Inc.

Surrozen Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Surrozen Reports Fourth Quarter and Full Year 2025 Financial Results and Business Update
March 23, 2026 12:22 ET | Source: Research and Markets

U.S. AI-driven Diabetic Retinopathy Screening Market Trends 2026-2033 Featuring Profiles of Eyenuk, Digital Diagnostics, AEYE Health, Optomed, IRIS and Other Key Players

Dublin, March 23, 2026 (GLOBE NEWSWIRE) -- The "U.S. AI-driven Diabetic Retinopathy Screening Market Size, Share & Trends Analysis Report by Component, Screening, Deployment Mode, End Use, and...
March 23, 2026 11:00 ET | Source: F. Hoffmann-La Roche Ltd

Roche inaugurates new research home for the Institute of Human Biology, pioneering human model systems to accelerate drug discovery and development

The new building is part of a CHF 1.4 billion site investment, reinforcing Roche’s commitment to Switzerland and the Basel life sciences clusterThe Institute of Human Biology (IHB) enables scientists...
March 23, 2026 08:30 ET | Source: CDT Equity Inc.

CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy

CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy
March 23, 2026 07:02 ET | Source: Ocugen

Ocugen to Host Webcast on Tuesday, March 24 at 8 a.m. EDT to Discuss Phase 2 Clinical Trial Data for OCU410—Modifier Gene Therapy for Geographic Atrophy

MALVERN, Pa., March 23, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced...
March 23, 2026 07:00 ET | Source: Curative Biotechnology, Inc. 

Curative Biotechnology Announces Reverse Stock Split and Strategic Progress Toward OTCQB Uplisting

Strengthening Capital Structure and Advancing Clinical Development Strategy Palm Beach Gardens, FL, March 23, 2026 (GLOBE NEWSWIRE) -- Curative Biotechnology, Inc. (OTC: CUBT) (“Curative” or the...
March 20, 2026 18:48 ET | Source: Global Down Syndrome Foundation

GLOBAL Marks World Down Syndrome Day with Publication of Milestone Review of New Medical Guideline

DENVER, CO, March 20, 2026 (GLOBE NEWSWIRE) -- The Global Down Syndrome Foundation (GLOBAL) is proud to announce that the Agency for Healthcare Research and Quality (AHRQ) systemic review of the new...
March 20, 2026 14:52 ET | Source: California University of Science and Medicine

All California University of Science and Medicine MD Graduates Receive Residency Placements during Match Day 2026

Colton, California, March 20, 2026 (GLOBE NEWSWIRE) -- California University of Science and Medicine (CUSM) today announced that the 2026 MD graduating class received residency placements as part of...
March 19, 2026 10:28 ET | Source: Spherix Global Insights

CAR-T Moves Upstream in Multiple Myeloma as Physicians Signal Shift in Treatment Sequencing

Exton, PA, March 19, 2026 (GLOBE NEWSWIRE) -- Spherix Global Insights’ Q1 2026 update of RealTime Dynamix™: Multiple Myeloma findings point to a clear inflection in treatment strategy, as physicians...